Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

ImmunoGen Inc (NASDAQ:IMGN)

7.28
Delayed Data
As of Feb 12
 +0.19 / +2.68%
Today’s Change
6.77
Today|||52-Week Range
19.43
-46.35%
Year-to-Date

Today’s Trading

Previous close7.09
Today’s open7.24
Day’s range6.77 - 7.35
Volume1,030,383
Average volume (3 months)1,047,745
Market cap$633.8M
Dividend yield--
Data as of 4:14pm ET, 02/12/2016

Growth & Valuation

Earnings growth (last year)+14.46%
Earnings growth (this year)-102.09%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)+42.82%
P/E ratioNM
Price/Sales14.46
Price/Book17.95

Competitors

 Today’s
change
Today’s
% change
AIMTAimmune Therapeutics...+0.09+0.56%
PACBPacific Biosciences ...-0.13-1.40%
ADAPAdaptimmune Therapeu...+0.35+4.67%
MNTAMomenta Pharmaceutic...-0.03-0.29%
Data as of 4:00pm ET, 02/12/2016

Financials

Next reporting dateApril 22, 2016
EPS forecast (this quarter)-$0.32
Annual revenue (last year)$85.5M
Annual profit (last year)-$60.7M
Net profit margin-71.01%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Daniel M. Junius
Chief Financial Officer &
Executive Vice President
David B. Johnston
Corporate headquarters
Waltham, Massachusetts

Forecasts

Partner Offers